NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Proprio

Proprio

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.propriovision.com/

Last Round

Series B

Jul 27, 2023

Total Funding Raised

$73M

Company Overview

Proprio is a surgical technology company that develops an AI-powered surgical navigation platform designed to improve surgical accuracy and workflows through light field computer vision and real-time 3D visualization.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

surgical navigationspine surgerysurgical imaginglight field technologycomputer visionintraoperative guidancedigital surgerymedical AI3D visualizationsurgical roboticsFDA clearedsurgical techmedtechsurgical dataoperating room tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proprio Comparables

Compare Proprio with similar companies based on industry and business-model similarity.

Proprio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
83%
Activ Surgical
81%
VISIE Inc.
80%

Proprio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 27, 2023
Series AJun 17, 2020
SeedJan 31, 2019

Key People

Founding team and executive leadership

Samuel R. Browd

Founder, Chief Medical Officer, Board Member

Founding Team

Gabriel Jones

CEO

Executive Team

José Martins Oliveira

CEO

Executive Team

Luiz felipe Da silva

CEO

Executive Team

Proprio Investors

Notable investors and investment history

Proprio investors
InvestorRounds
Cota CapitalSeries B, Series A
Presence CapitalSeed
L2 VenturesSeed
Acequia CapitalSeed
BIRD B. AGSeries B
BOLD Capital PartnersSeries B, Series A
Acequia CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Partnered with the Harms Study Group for pediatric spinal deformity research.

  • May 16, 2025

    Job postings indicate strategic planning for a future public offering.

Proprio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Proprio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proprio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range2,831
Year Founded2016
Last FundingJul 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.